Cutler Group’s Vivani Medical VANI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,000
Closed -$1K 6097
2021
Q4
$1K Sell
6,000
-3,500
-37% -$25.6K ﹤0.01% 5161
2021
Q3
$8K Sell
9,500
-3,233
-25% -$36.4K ﹤0.01% 4153
2021
Q2
$12K Buy
12,733
+12,266
+2,627% +$237K ﹤0.01% 3758
2021
Q1
$1K Buy
+467
New +$6.97K ﹤0.01% 5391
2017
Q3
Sell
-3,067
Closed -$1K 6779
2017
Q2
$1K Sell
3,067
-950
-24% -$26.9K ﹤0.01% 6057
2017
Q1
$4K Buy
4,017
+3,350
+502% +$128K ﹤0.01% 4963
2016
Q4
$2K Buy
+667
New +$38.1K ﹤0.01% 5724
2016
Q3
Sell
-2,100
Closed -$1K 7423
2016
Q2
$1K Sell
2,100
-421
-17% -$43.8K ﹤0.01% 6290
2016
Q1
$12K Buy
2,521
+1,842
+271% +$212K ﹤0.01% 3880
2015
Q4
$15K Buy
+679
New +$99.4K ﹤0.01% 3715

Other funds holding VANI

Cutler Group's VANI Position: Q4 2022 in Review

Cutler Group sold out of Vivani Medical (VANI) in Q4 2022, closing a stake of 366 shares — an estimated $596 sold.

Cutler Group first reported a position in VANI in Q4 2015 and held it in 11 quarters. The position peaked at $121K in Q2 2021. 35 funds tracked by Wall St. Rank hold VANI as of Q4 2022.

  • Cutler Group reported no remaining Vivani Medical position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 366 Vivani Medical shares in Q4 2022, an estimated $596.
  • Cutler Group first reported a position in Vivani Medical in Q4 2015 and held it in 11 quarters.
  • Cutler Group's Vivani Medical position peaked at $121K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.